Cardiovascular imaging, a fundamental component in the diagnosis and management of cardiovascular diseases, has a great potential for evolution with the advent of technologies such as artificial intelligence (AI), virtual reality (VR), and the metaverse. 1,2 These innovations promise to enhance diagnostic accuracy, streamline workflows, and transform patient-clinician interactions. However, their true impact on clinical practice remains a topic of debate. 3 While AI’s potential to automate image analysis is actively being explored, the roles of VR and the metaverse are less clear, often appearing more aspirational than immediately practical. 4 This article presents an opinion challenging established thinking about these technologies, focusing on whether they will truly revolutionize cardiovascular imaging or simply augment current approaches without fundamentally changing the landscape.